Methods for drug discovery, disease treatment, and diagnosis using metabolomics

a metabolomics and drug discovery technology, applied in the field of drug discovery, disease treatment, and diagnosis using metabolomics, can solve the problems of expensive and time-consuming procedures, and achieve the effect of quick and relatively inexpensive methods, rapid screening and identification

Inactive Publication Date: 2002-01-24
CORNELL RES FOUNDATION INC +1
View PDF4 Cites 71 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

0081] The methods of the invention are particularly useful because they offer a quick and relatively inexpensive method to determine whether a certain test compound is likely toxic to a body organ, such as the liver. This allows for pharmaceutical companies to quickly screen and identify compounds which are toxic and to direct their research towards non-toxic compounds.

Problems solved by technology

For example, once a novel gene or target is discovered by genomics, the investigators must first validate the target using expensive and time consuming procedures which are far removed from the actual disease state.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0281] Method for Obtaining a Small Molecule Profile of a Cellular Compartment

[0282] Method for Obtaining a Small Molecule Profile of Mitochondria using HPLC

[0283] The following method demonstrates how small molecules are isolated from mitochondria for methods as described herein.

[0284] Mitochondrial Isolation

[0285] Mitochondria from a mammalian source are isolated by differential centrifugation in 140 mM KCI and 20 mM Hepes, pH 7.4. Following the final wash, mitochondria are resuspended in the same buffer and aliquots are quick frozen in liquid nitrogen. Protein determinations are carried out by Lowry using the Sigma Protein Assay Kit P5656).

[0286] Other mitochondrial samples are purified using a modified version of a published protocol (Rigobello et al. (1995) Arch. Biochem. Biophys. 319, 225-230). Mammalian liver mitochondria are obtained after decapitation of the subjects. The livers are dissected out and are placed in an ice-cold solution containing 250 mM mannitol, 75 mM sucro...

example 2

[0295] Method for Analyzing Metabolic Disorders Using Small Molecule Profiles

[0296] Method for Analyzing Differences in Small Molecule Profiles of Genetically Altered Mice After Short Term Diet Variations

[0297] 15 female C57B1 / 6J ob / ob mice and lean littermate controls (15 female C57B1 / 6J ? / +) and 15 male C57B1 / Ks db / db mice and lean littermate controls (15 male C57B1 / ks + / +) are obtained from Jackson labs at 4.5 weeks of age, and are housed individually on normal mouse chow (West, D. B., 1992, Am. J Physiol. 262:R1025-R1032) for 1 week prior to the initiation of the study. The four groups of 15 mice each are then sacrificed by CO.sub.2 euthanasia and tissues are then collected. Body weight (grams) of the four groups of mice at the time of sacrifice are measured. Small molecule profiles from cells from the hypothallumus are then obtained from each group of mice and compared.

[0298] The mice (normal, lean, ob / ob, db / db, and / or tub / tub) are fed normally prior to the initiation of the e...

example 3

[0301] Comparison of Small Molecule Profiles of Different Types of Immune Cells

[0302] Method for Comparing the Small Molecule Profiles of TH1 and TH2 Cells

[0303] The transgenic T cell example is used to identify cellular small molecules present in TH2 cells. The identified small molecules are be present in different amounts in TH2 cells compared to TH1 cells.

[0304] Transgenic Mice

[0305] Naive CD4.sup.+ cells are obtained from the spleens and / or lymph nodes of unprimed transgenic mouse strains harboring a T cell receptor (TCR) recognizing ovalbumin (Murphy et al., 1990, Science 250:1720).

[0306] Ova-specific Transgenic T Cells

[0307] Suspensions of ova-specific T cells are co-cultured with stimulatory peptide antigen and antigen presenting cells essentially as described in Murphy et al. (Murphy et al., 1990, Science 250:1720). Briefly, 2-4.times.10.sup.6 T cells are incubated with approximately twice as many TA3 antigen presenting cells in the presence of 0.3 .mu.M Ova peptide. THI cul...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
wavelengthsaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to view more

Abstract

The small molecule profiles of cells are compared to identify small molecules which are modulated in altered states. Cellular small molecule libraries, methods of identifying tissue sources, methods for treating genetic and non-genetic diseases, and methods for predicting the efficacy of drugs are also discussed.

Description

[0001] This application claims priority to U.S. Provisional Application Ser. No. 60 / 239,340, entitled "Methods for Drug Discovery, Disease Treatment, and Diagnosis Using Metabolomics" filed on Oct. 11, 2000; U.S. Provisional Application Ser. No. 60 / 239,541, entitled "Methods for Drug Discovery, Disease Treatment, and Diagnosis Using Metabolomics" filed on Oct. 10, 2000; U.S. Provisional Application Ser. No. 60 / 197,117, entitled "Small Molecule Profiles of Cells and Methods Of Use Thereof," filed on Apr. 14, 2000; and U.S. Provisional Application Ser. No. 60 / 197,085, entitled "Cellular Small Molecule Libraries," filed on Apr. 14, 2000. The entire contents of each of the aforementioned applications are hereby incorporated herein by reference.BACKGROUND OF INVENTION[0002] Living organisms are autonomous chemical systems which include diverse sets of small molecules. Small molecules found in living systems include, for example, sugars, fatty acids, amino acids, nucleotides, and intermed...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K45/00A61P3/00A61P25/00A61P31/12A61P35/00A61P37/00C12Q1/02C12Q1/68G01N33/15G01N33/50
CPCG01N33/5091G01N33/6803G01N2800/52A61P25/00A61P3/00A61P31/12A61P35/00A61P37/00Y02A90/10
Inventor KADDURAH-DAOUK, RIMAKRISTAL, BRUCE
Owner CORNELL RES FOUNDATION INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap